SA expected to begin piloting HIV prevention shot in early 2023

Posted in: Access to Medicines, HIV/AIDS, Latest

South Africa is expected to begin piloting the every-other-month HIV prevention shot early next year, according to the international medicine financing initiative Unitaid. New modelling shows that the injection could prevent as many as 52 000 new HIV infections in the next two decades. But to be cost-effective in South Africa, the research argues, the price of the injection must fall to levels drugmaker ViiV Healthcare says are unrealistic. Laura Lopez Gonzalez reports.

SA expected to begin piloting HIV prevention shot in early 2023

Climate change can set back maternal health, says researcher

Posted in: Healthcare system, Latest, Reproductive Health

Researchers around the world are drawing an ever-more distinct line between rising global temperatures and negative effects on maternal, foetal, and infant health. One of these researchers is Professor Matthew Chersich of the Wits Reproductive Health and HIV Research Institute. Ufrieda Ho chatted to Chersich after he delivered his inaugural lecture at the end of August.

Climate change can set back maternal health, says researcher

Women in Health: From test tubes to impacting lives – Dr Thesla Palanee-Phillips on making a difference with science

Posted in: Healthcare system, HIV/AIDS, Latest

Dr Thesla Palanee-Phillips is the Director of Clinical Trials at the Wits Reproductive Health and HIV Institute (Wits RHI) at the University of the Witwatersrand. As part of Spotlight’s Women in Health series, Elri Voigt spoke to her about what set her off into a career in science, the significance of the ASPIRE trial that she co-chaired, and juggling motherhood and her career.

Women in Health: From test tubes to impacting lives – Dr Thesla Palanee-Phillips on making a difference with science

Experts welcome new HIV treatments for kids

Posted in: Child health, HIV/AIDS, Latest

New child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for children living with HIV in South Africa and how long it will take for these medicines to become widely available.

Experts welcome new HIV treatments for kids

Over 3million people on new HIV drug, but not all smooth sailing

Posted in: Healthcare system, HIV/AIDS, Latest

In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking of switching millions of people to a new drug has gone.

Over 3million people on new HIV drug, but not all smooth sailing

HIV prevention ring approved, but next steps unclear

Posted in: Healthcare system, HIV/AIDS, Latest

The South African Health Products Regulatory Authority recently approved the use of the monthly dapivirine vaginal ring for women 18 years and older to reduce the risk of HIV infection. Thabo Molelekwa looks at the evidence for the ring’s efficacy and asks what plans there are for making it available to women in South Africa.

HIV prevention ring approved, but next steps unclear

Programme delivers comprehensive HIV prevention and SRH services to learners

Posted in: Child health, Edition 6: HIV & teens, Edition 9: State of HIV, Healthcare system, HIV/AIDS, Latest, Reproductive Health, SRHR

Even though the rate of new HIV infections in young women and adolescent girls remains stubbornly high, provision and uptake of pills that can prevent HIV infection have generally been slow and lagging. One potential solution presented at the recent Conference on Retroviruses and Opportunistic Infections is to provide the pills at schools. Tiyese Jeranji reports.

Programme delivers comprehensive HIV prevention and SRH services to learners

Start planning HIV prevention injection rollout, experts say

Posted in: Spotlight

There is no time to waste in planning the South African rollout of cabotegravir (CAB LA), the long-lasting antiretroviral injection approved for use in the United States in December 2021, say local health experts.

Start planning HIV prevention injection rollout, experts say

HPV: What is happening with SA’s other relatively new vaccine programme?

Posted in: COVID-19, Edition 6: HIV & teens, Healthcare system, HIV/AIDS, Latest, Reproductive Health, SRHR

In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.

HPV: What is happening with SA’s other relatively new vaccine programme?

HIV and cervical cancer: Behind SA’s extraordinarily high numbers

Posted in: HIV/AIDS, Latest, Reproductive Health

A study recently published in The Lancet found that women living with HIV made up an astonishing 63.4% of new cervical cancer cases in South Africa in 2018. Elri Voigt spoke to local experts about the links between HIV and cervical cancer in South Africa and how cervical cancer is prevented, tested for, and treated in the public sector.